题名

癌症病人嗜中性白血球低下臨床照護指引

并列篇名

Clinical Practice Guideline on Neutropenia in Cancer Patients

DOI

10.6880/TJON.201112/SP_11.04

作者

洪敏瑛(Ming-Ying Hong)；邱文姿(Wen-Tzu Chiu)；陳淑娟(Shu-Chuan Chen)；戴仕卿(Shih-Ching Tai)；蕭逸美(Ye-Mei Hsiao)

关键词

癌症 ； 化學治療 ； 嗜中性白血球低下 ； 感染 ； 指引 ； cancer ； chemotherapy ； neutropenia ； infection ； guideline

期刊名称

腫瘤護理雜誌

卷期/出版年月

11卷增訂刊（2011 / 12 / 01）

页次

41 - 60

内容语文

繁體中文
中文摘要

嗜中性白血球低下是癌症病人接受抗癌相關治療，如化學治療、放射線治療等，常見的骨髓功能被抑制反應，導致免疫力低下，有高風險之感染率與死亡率，臨床護理人員對此須有高度的評估與照護能力。有鑑於國內缺乏本土性之癌症護理照護指引，故本文主要目的為針對嗜中性白血球低下之癌症病人，提供護理人員一套本土的護理照護準則與護理指導方針，內容包含四大部分（一）評估：病史評估、身體評估、檢驗室檢查報告；（二）確認問題：針對感染風險分為低危險性、高危險性與極高危險性三級；（三）處置與照護：包括低危險性病人之預防性門診醫療處置及居家照護、高危險性與極高危險性病人住院醫療處置及護理照護；（四）持續照護。期望藉由本文能增進本土護理人員的專業知能及病人自我照護的處理能力，預防感染發生，減少醫療成本的支出，同時亦提升癌症病人的照護品質。
英文摘要

Neutropenia is a common and severe myelosuppressive side effect in patients receiving anti-cancer treatment, such as chemotherapy and radiotherapy. Neutropenia can result in immunecompromised effects, have the risks of infection rate and mortality rates. Nurses must have the abilities to assess the patients and provide nursing care for neutropenia. Clinical practice guideline in oncology nursing are needed in Taiwan. This paper is to provide nurses in Taiwan with the nursing care standards and practice guidelines for the neutropenia patients. There are four major parts: (1) patient assessment including physical assessment and laboratory data, (2) problem identification: three levels including low, high, and extremely high of risk of infection, (3) management and nursing care including the prevention of neutropenia in low risk patients at home care and the treatment of high risk patients at hospital, and the care of exteremely high risk patients, and (4) continued assessment and nursing care. It is expect that this paper can improve the oncology nurses' care competences and patients' self-care management abilities, reduce the infection rate and medical cost in patients with neutropenia, and improve the care quality in oncology nursing units.
主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 內科
醫藥衛生 > 社會醫學
参考文献
  1. (2005).Guidelines for the use of antimicrobial agents in patients with febrile neutropenia in Taiwan.J Microbiol Immunol Infect,38(6),455-457.
  2. NCCN: Cancer and COVID-19 Vaccination Version 6.0 https://www.nccn.org/docs/default-source/covid-19/2021_covid-19_vaccination_guidance_v5-0.pdf?sfvrsn=b483da2b_116. Published 2022. Updated 04/27/2022. Accessed May 30, 2022.
  3. Cancer and COVID-19 Vaccination Version 3. https://www.nccn.org/docs/default-source/covid-19/2021_covid-19_vaccination_guidance_v4-0.pdf?sfvrsn=b483da2b_70. Published 2021. Updated 2021/06/09. Accessed July 30, 2022.
  4. Adeboyeje, G,Agiro, A,Malin, J,Fisch, MJ,DeVries, A(2017).Reducing Overuse of Colony-Stimulating Factors in Patients With Lung Cancer Receiving Chemotherapy: Evidence From a Decision Support-Enabled Program.J Oncol Pract,13(4),e337-e345.
  5. Agreiter, I,Kozijn, AE,Bakunina, K(2021).Contribution of nurses to protective environment in haematopoietic cell transplant setting: an international survey by the European Society for Blood and Marrow Transplantation.Bone Marrow Transplantation,56(6),1433-1440.
  6. Aguilar-Guisado, M,Espigado, I,Martin-Pena, A(2017).Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.Lancet Haematol,4(12),e573-e583.
  7. Aras, E,Bayraktar-Ekincioglu, A,Kilickap, S(2020).Risk assessment of febrile neutropenia and evaluation of G-CSF use in patients with cancer: a real-life study.Support Care Cancer,28(2),691-699.
  8. Baden LR, Swaminathan S, Almyroidis NG, et al. Prevention and Treatment of Cancer-Related Infections, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw Web site. Retrieved Oct 6, 2020, from https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf. Published 2020. Accessed October 6, 2020.
  9. Berkley, SF,Hightower, AW,Broome, CV,Reingold, AL(1987).The Relationship of Tampon Characteristics to Menstrual Toxic Shock Syndrome.JAMA,258(7),917-920.
  10. Biagioli, V,Piredda, M,Alvaro, R,de Marinis, MG(2017).The experiences of protective isolation in patients undergoing bone marrow or haematopoietic stem cell transplantation: systematic review and metasynthesis.Eur J Cancer Care (Engl),26(5)
  11. Blot, F,Nitenberg, G,Chachaty, E(1999).Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures.Lancet,354(9184),1071-1077.
  12. Borowski, B,Benhamou, E,Pico, JL,Laplanche, A,Margainaud, JP,Hayat, M(1994).Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care.Eur J Cancer B Oral Oncol,30b(2),93-97.
  13. Bundgaard, H,Bundgaard, JS,Raaschou-Pedersen, DET(2021).Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.Ann Intern Med,174(3),335-343.
  14. Carmona-Bayonas, A,Jimenez-Fonseca, P,de Castro, EM(2019).SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018).Clin Transl Oncol,21(1),75-86.
  15. Chen, C,Chan, A,Yap, K(2013).Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy.J Oncol Pharm Pract,19(2),111-120.
  16. Chen, CY,Tang, JL,Hsueh, PR(2004).Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.J Formos Med Assoc,103(7),526-532.
  17. Climo, MW,Yokoe, DS,Warren, DK(2013).Effect of daily chlorhexidine bathing on hospital-acquired infection.New England Journal of Medicine,368(6),533-542.
  18. Conley, SB,Buckley, P,Magarace, L,Hsieh, C,Pedulla, LV(2017).Standardizing Best Nursing Practice for Implanted Ports: Applying Evidence-based Professional Guidelines to Prevent Central Line-Associated Bloodstream Infections.J Infus Nurs,40(3),165-174.
  19. Cupp, J,Culakova, E,Poniewierski, MS,Dale, DC,Lyman, GH,Crawford, J(2018).Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia.Clin Lung Cancer,19(2),e163-e169.
  20. de Sousa Lima, CM,Fujishima, MAT,de Paula Lima, B,Mastroianni, PC,de Sousa, FFO,da Silva, JO(2020).Microbial contamination in herbal medicines: A serious health hazard to elderly consumers.BMC Complement Med Ther,20(1),17.
  21. Duffy, L(2009).Care of immunocompromised patients in hospital.Nurs Stand,23(36),35-41.
  22. Eaton, LH(ed.),Tipton, JM(ed.),Society, ON(ed.)(2009).Putting Evidence Into Practice: Improving Oncology Patient Outcomes.Oncology Nursing Society.
  23. Egan, G,Robinson, PD,Martinez, JPD(2019).Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials.Cancer Med,8(10),4536-4546.
  24. Fletcher, S(2005).Catheter-related bloodstream infection.Continuing Education in Anaesthesia Critical Care & Pain,5(2),49-51.
  25. Freifeld, AG,Bow, EJ,Sepkowitz, KA(2011).Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.Clin Infect Dis,52(4),e56-e93.
  26. Gorski, LA,Hadaway, L,Hagle, ME(2021).Infusion Therapy Standards of Practice, 8th Edition.J Infus Nurs,44(1S Suppl 1),S1-s224.
  27. Hong, CHL,Gueiros, LA,Fulton, JS(2019).Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines.Support Care Cancer,27(10),3949-3967.
  28. Hospita HaEYHNTQscfOaHCH. Guidelines for the prevention and management of infection in adult neutropenic patients. https://www.hey.nhs.uk/wp/wp-content/uploads/2018/02/neutropenicSepsis.pdf. Published 2018. Accessed Sep, 2021.
  29. Klastersky, J,de Naurois, J,Rolston, K(2016).Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.Ann Oncol,27(suppl 5),v111-v118.
  30. Klastersky, J,Paesmans, M,Rubenstein, EB(2000).The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.J Clin Oncol,18(16),3038-3051.
  31. Larson, EL,Nirenberg, A(2004).Evidence-based nursing practice to prevent infection in hospitalized neutropenic patients with cancer.Oncology nursing forum,31(4),717-725.
  32. Lee, YM,Lockwood, C(2013).Prognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.Int J Nurs Pract,19(6),557-576.
  33. Lin, JC,Jan, JS,Hsu, CY,Liang, WM,Jiang, RS,Wang, WY(2003).Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.J Clin Oncol,21(4)
  34. Link, H,Kerkmann, M,Holtmann, L,Ortner, P,Working Groups Supportive C, Medical Oncology within the German Cancer S(2019).G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey.Support Care Cancer,27(4),1459-1469.
  35. Lucas, AJ,Olin, JL,Coleman, MD(2018).Management and Preventive Measures for Febrile Neutropenia.P T,43(4),228-232.
  36. Lyman, GH,Allcott, K,Garcia, J(2017).The effectiveness and safety of same-day versus nextday administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review.Support Care Cancer,25(8),2619-2629.
  37. Marrs, JA(2006).Care of patients with neutropenia.Clin J Oncol Nurs,10(2),164-166.
  38. Mathur, P(2011).Hand hygiene: back to the basics of infection control.Indian J Med Res,134(5),611-620.
  39. McDonald, LC,Gerding, DN,Johnson, S(2018).Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).Clin Infect Dis,66(7),e1-e48.
  40. Moriyama, B,Henning, SA,Leung, J(2012).Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.Mycoses,55(4),290-297.
  41. Munoz-Price, LS,Banach, DB,Bearman, G(2015).Isolation precautions for visitors.Infect Control Hosp Epidemiol,36(7),747-758.
  42. Nirenberg, A,Parry Bush, A,Davis, A,Friese, CR,Wicklin Gillespie, T,Rice, RD(2006).Neutropenia: state of the knowledge part II.Oncol Nurs Forum,33(6),1202-1208.
  43. Nucci, M,Thompson-Moya, L,Guzman-Blanco, M(2013).Recommendations for the management of candidemia in adults in Latin America. Latin America Invasive Mycosis Network.Rev Iberoam Micol,30(3),179-188.
  44. Ohno, T,Kato, S,Wakatsuki, M(2006).Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone.Gynecol Oncol,103(1),94-99.
  45. Ortega, M,Marco, F,Soriano, A(2011).Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008.J Hosp Infect,77(2),157-161.
  46. Paul, M,Lador, A,Grozinsky-Glasberg, S,Leibovici, L(2014).Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.Cochrane Database Syst Rev,2014(1),CD003344.
  47. Pillinger, KE,Bouchard, J,Withers, ST(2020).Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature.Ann Pharmacother,54(6),594-610.
  48. Pittet, D,Allegranzi, B,Sax, H(2006).Evidence-based model for hand transmission during patient care and the role of improved practices.Lancet Infect Dis,6(10),641-652.
  49. Recommendations of CDC tIDSoA, the American Society of Blood and Marrow Transplantation(2000).Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.MMWR Recomm Rep,49(Rr-10),1-125, ce121-127.
  50. Rutala WA, Weber DJ. Guideline for disinfection and sterilization in healthcare facilities, 2008. https://stacks.cdc.gov/view/cdc/47378
  51. Sah, SK,Karn, A,Shah, A(2019).Incidence and attributes of chemotherapy induced myelotoxicity, anemia and neutropenia in adults with cancer in Nepal: A cross-sectional observational study.J Oncol Pharm Pract,25(8),1823-1830.
  52. Scottish Intercollegiate Guidelines Network (2015). SIGN grading system 1999-2012. http://www.sign.ac.uk/assets/sign_grading_system_1999_2012.pdf. Accessed October 6, 2020.
  53. Sehulster, L,Chinn, RY(2003).Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).MMWR Recomm Rep,52(Rr-10),1-42.
  54. Senan, S,Brade, A,Wang, LH(2016).PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.J Clin Oncol,34(9),953-962.
  55. Sifuentes, LY,Gerba, CP,Weart, IF,Engelbrecht, KC,Koenig, DW(2013).Microbial contamination of hospital reusable cleaning towels.American Journal of Infection Control,41(10),912-915.
  56. Sonbol, MB,Jain, T,Firwana, B(2019).Neutropenic diets to prevent cancer infections: updated systematic review and meta-analysis.BMJ Support Palliat Care,9(4),425-433.
  57. Steven Pergam LRB, Brahm Segal, Gregory Abel..etc. NCCN: Cancer and COVID-19 Vaccination. https://www.nccn.org/covid-19/pdf/COVID-19_Vaccination_Guidance_V1.0.pdf. Published 2021. Accessed May 30, 2022.
  58. Styczynski, J,Tridello, G,Donnelly, JP(2018).Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on healthcare facilities.Bone Marrow Transplant,53(9),1131-1138.
  59. Tacke, D,Buchheidt, D,Karthaus, M(2014).Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.Ann Hematol,93(9),1449-1456.
  60. Tai, E,Guy, GP,Dunbar, A,Richardson, LC(2012).Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012.J Oncol Pract,13(6),e552-e561.
  61. Taplitz, RA,Kennedy, EB,Bow, EJ(2018).Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.J Clin Oncol,36(14),1443-1453.
  62. Toles, A(2002).Artificial nails: Are they putting patients at risk? A review of the research.Journal of Pediatric Oncology Nursing,19(5),164-171.
  63. Tomblyn, M,Chiller, T,Einsele, H(2009).Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.Biol Blood Marrow Transplant,15(10),1143-1238.
  64. Ullmann, AJ,Schmidt-Hieber, M,Bertz, H(2016).Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Ann Hematol,95(9),1435-1455.
  65. USFaD A. Safe Food Handling. https://www.fda.gov/food/buy-store-serve-safe-food/safe-food-handling. Published 2017. Accessed February 09, 2021.
  66. van Dalen, EC,Mank, A,Leclercq, E(2016).Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.Cochrane Database Syst Rev,4(4),Cd006247.
  67. Wang, L,Baser, O,Kutikova, L,Page, JH,Barron, R(2015).The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials.Support Care Cancer,23(11),3131-3140.
  68. Wang, W,Hou, X,Yan, J(2017).Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.BMC Cancer,17(1),510.
  69. Weycker, D,Barron, R,Kartashov, A,Legg, J,Lyman, GH(2014).Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.J Oncol Pharm Pract,20(3),190-198.
  70. Weycker, D,Bensink, M,Lonshteyn, A,Doroff, R,Chandler, D(2019).Use of colony-stimulating factor primary prophylaxis and incidence of febrile neutropenia from 2010 to 2016: a longitudinal assessment.Curr Med Res Opin,35(6),1073-1080.
  71. Yokoe, D,Casper, C,Dubberke, E(2009).Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated.Bone Marrow Transplant,44(8),495-507.
  72. Zhang, Y,Chen, L,Hu, GQ(2019).Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.N Engl J Med,381(12),1124-1135.
  73. Zheng, B,Toarta, C,Cheng, W,Taljaard, M,Reaume, N,Perry, JJ(2020).Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis.Crit Rev Oncol Hematol,149,102922.
  74. Zimmer, AJ,Freifeld, AG(2019).Optimal Management of Neutropenic Fever in Patients With Cancer.J Oncol Pract,15(1),19-24.
  75. Zitella, LJ,Friese, CR,Hauser, J(2006).Putting evidence into practice: prevention of infection.Clin J Oncol Nurs,10(6),739-750.
  76. 中華民國血液病學會（2021）。血液病患者COVID疫苗注射參考。取自http://www.hematology.org.tw/web2/project/index.php?act=pb&id=16，引用2022/07/30。
  77. 李選（編）(2017).護理研究與應用.臺北市:華杏.
  78. 周繡玲,謝嘉芬,李佳諭,江孟冠,紀雯真(2011)。癌症病人口腔黏膜炎臨床照護指引。腫瘤護理雜誌，11，61-85。
  79. 林明瀅,王復德(2009)。移植病人退伍軍人病之防治策略。感染控制雜誌，19(5)，292-301。
  80. 洪敏瑛,邱文姿,陳淑娟,戴仕卿,蕭逸美(2011)。癌症病人嗜中性白血球低下臨床照護指引。腫瘤護理雜誌，11，41-60。
  81. 洪敏瑛,邱文姿,陳淑娟,戴仕卿,蕭逸美(2013)。癌症病人嗜中性白血球低下臨床照護指引－第一版與第二版修訂對照表。腫瘤護理雜誌，13，79-92。
  82. 財團法人台灣臨床進階教育基金會（2021）。治療中的癌症病人Covid-19疫苗接種建議。取自https://www.tace.org.tw/clinical-education/治療中的癌症病人covid-19-疫苗接種建議，引用2022/07/30。
  83. 張黎露,張瀞文,周文珊,林思岑(2011)。癌症病人常用中心靜脈導管臨床照護指引。腫瘤護理雜誌，11，15-40。
  84. 衛生福利部（2020，11月10日）。發布修正「醫療機構設置標準」第15條及第3條附表（一）醫院設置基準表。取自https://www.mohw.gov.tw/cp-18-56614-1.html，引用2021/01/18。
  85. 衛生福利部疾病管制署（2020年05月16日 ）。酒精性乾洗手液產品之建議。 取自 https://www.cdc.gov.tw/File/Get/arfscl2AlldHjH66PnFWVA，引用2021/01/18。
  86. 衛生福利部疾病管制署（2015年10月28 日）。個人防護裝備使用建議。取自https://www.cdc.gov.tw/Category/ListContent/NO6oWHDwvVfwb2sbWzvHWQ?uaid=2_LQNoINv66A3OHJxbuK1w，引用2021/01/18。
  87. 衛生福利部疾病管制署（2022）。疫苗接種對象與相關作業指引（接種實務、核心教材）。取自https://www.cdc.gov.tw/Category/MPage/bVELR0eNHUQd_RE80ldpPQ. Published 2022，引用2022/05/30。
  88. 衛生福利部疾病管制署(2007).退伍軍人菌控制作業建議指引.
  89. 衛生福利部疾病管制署（2018，11版）。各項預防接種間隔時間一覽表。取自https://www.cdc.gov.tw/Category/List/IpWZqtnmkJfQPfgnaP4lnw，引用2021/01/18。
  90. 羅如君,洪美娟,盛望徽(2016)。使用2% chlorhexidine擦澡在減少重症病患醫療照顧相關感染及預防多重抗藥性菌株移生的應用。感染控制雜誌，26(2)，58-64。
被引用次数
  1. 劉婷婷(Ting-Ting Liou);林素月(Su-Yueh Lin)(2021)。一位幼兒期初罹患急性淋巴性白血病的照護經驗。彰化護理。28(2)。68-79。 
print cancel